Accessibility Menu
 

Anbio Biotechnology

(NASDAQ) NNNN

Current Price$23.04
Market Cap$1.00B
Since IPO (2025)+296%
5 YearN/A
1 Year+208%
1 Month-6%

Anbio Biotechnology Financials at a Glance

Market Cap

$1.00B

Revenue (TTM)

$17.81M

Net Income (TTM)

$7.50M

EPS (TTM)

$0.06

P/E Ratio

361.87

Dividend

$0.00

Beta (Volatility)

0.40 (Low)

Price

$23.04

Volume

699

Open

$22.74

Previous Close

$23.04

Daily Range

$22.74 - $23.54

52-Week Range

$5.89 - $55.65

NNNN News

No articles available.

NNNN: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Anbio Biotechnology

Industry

Biotechnology

Employees

27

CEO

Michael Lau, PhD, MBA

Headquarters

Frankfurt am Main, 60437, DE

NNNN Financials

Key Financial Metrics (TTM)

Gross Margin

90%

Operating Margin

26%

Net Income Margin

37%

Return on Equity

11%

Return on Capital

6%

Return on Assets

9%

Earnings Yield

0.28%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.00B

Shares Outstanding

43.89M

Volume

699

Short Interest

0.00%

Avg. Volume

58.45K

Financials (TTM)

Gross Profit

$5.89M

Operating Income

$2.00M

EBITDA

$2.57M

Operating Cash Flow

$2.08M

Capital Expenditure

$0.00

Free Cash Flow

$2.08M

Cash & ST Invst.

$11.76M

Total Debt

$0.00

Anbio Biotechnology Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

$5.01M

+51.5%

Gross Profit

$4.62M

+138.1%

Gross Margin

92.32%

N/A

Market Cap

$1.00B

N/A

Market Cap/Employee

$37.18M

N/A

Employees

27

N/A

Net Income

$4.15M

+152.4%

EBITDA

$4.15M

+151.0%

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Net Cash

$15.76M

+49.3%

Accounts Receivable

$4.36M

+121722.7%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

8.69%

N/A

Return on Invested Capital

6.01%

N/A

Free Cash Flow

$1.60M

N/A

Operating Cash Flow

$1.60M

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
TALKTalkspace, Inc.
$5.13-0.19%
KALVKalVista Pharmaceuticals, Inc.
$16.46-0.84%
AVNSAvanos Medical, Inc.
$13.65+1.87%
CMPSCOMPASS Pathways plc
$5.22-2.25%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$43.62-0.02%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.61+0.00%
IBRXImmunityBio
$7.42-0.21%
SMCISuper Micro Computer
$22.23+0.03%

Questions About NNNN

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.